Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State

NCT06931665 — Not applicable, Recruiting, 26 participants, University of Basel

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State: a Randomized, Controlled Cross-over Study

RegistryNCT06931665, acronym EMCS
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: none, treatment
Enrollment26 (Estimated)
SponsorUniversity of Basel (Other); collaborators: Rehab Basel
ConditionsMinimally Conscious State
InterventionsAnimal Assisted Occupational Therapy (Procedure)
Datesstart 2025-07-08, primary completion 2027-04-01 (estimated), completion 2027-04-01 (estimated), first posted 2025-04-17, last updated 2025-12-18
Locations2 sites in Switzerland

Related Papers Related Patents Related Grants Related Experts
All trials for Minimally Conscious State All trials of Animal Assisted Occupational Therapy

-Summary

This study aims to explore the impact of Animal Assisted Therapy (AAT) on brain signal complexity in patients with minimally conscious state (MCS) by analyzing electroencephalogram (EEG) entropy. MCS patients typically exhibit reduced brain entropy compared to healthy individuals, indicating lower brain complexity. The study will assess whether AAT can enhance this complexity, which is crucial for understanding consciousness levels. Entropy, a measure of randomness in brain activity, will be used to evaluate AAT's effectiveness. In addition, electrocardiography (ECG), electrodermal activity (EDA) and behavioral measurements will also be collected.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
AAT-TAU-AAT-TAU (arm 1)ExperimentalProcedure: Animal Assisted Occupational TherapyEach patient will undergo two therapy sessions per week, with a total of four sessions integrated into their clinical routine. In this arm, patients will start with the AAT intervention, followed by a TAU intervention in the same week. In week two, the patient will again receive an AAT intervention followed by the last TAU intervention.
TAU-AAT-TAU-AAT (arm 2)ExperimentalProcedure: Animal Assisted Occupational TherapyEach patient will undergo two therapy sessions per week, with a total of four sessions integrated into their clinical routine. In this arm, patients will start with the TAU intervention, followed by an AAT intervention in the same week. In week two, the patient will again receive a TAU intervention followed by the last AAT intervention.
  • Animal Assisted Occupational Therapy (Procedure), also known as Animal Assisted Therapy, AAT, ergotherapy: AAT is an ergotherapy including an animal. AAT is a specific type of Animal Assisted Intervention (AAI) with a therapeutic aim.

+Outcome measures

Primary outcomes

  • EEG signal complexity 1 [Before, during and after AAT and TAU. Approximately three weeks.]: The EEG signal complexity is measured via entropy computed based on EEG recordings: • Sample Entropy (SampEn): score usually between 0 and 1 with higher score indicating higher entropy
  • EEG signal complexity 2 [Before, during and after AAT and TAU. Approximately three weeks.]: The EEG signal complexity is measured via entropy computed based on EEG recordings: • Lempel-Ziv complexity (LCZ): score usually between 0 and 1 with higher score indicating higher entropy
  • EEG signal complexity 3 [Before, during and after AAT and TAU. Approximately three weeks.]: The EEG signal complexity is measured via three measures of entropy computed based on EEG recordings: • Symbolic Transfer Entropy (STE): score usually between 0 and 1 with higher score indicating higher entropy

Secondary outcomes

  • Other physiological measures 1 [Before, during and after AAT and TAU. Approximately three weeks.]: • Heart rate (HR) in bpm
  • Other physiological measures 2 [Before, during and after AAT and TAU. Approximately three weeks.]: • Heart rate variability (HRV) measured by complexity index (CI): score usually between 0 and 1 with higher score indicating higher complexity
  • Other physiological measures 3 [Before, during and after AAT and TAU. Approximately three weeks.]: • Electrodermal activity (EDA) in uS

Other outcomes

  • Behavioral data assessing state of consciousness 1 [From enrollment to the end of treatment at 2 weeks. Day 1 and last day]: • Coma Recovery Scale - Revised (CRS-R): score from 0 to 23 with higher score indicating higher consciousness level
  • Behavioral data assessing state of consciousness 2 [From enrollment to the end of treatment at 2 weeks. Two pre-session measures per week, two post-session measures per week]: • Basler Vegetative State Assessment (BAVESTA): 22 items with a score from 0 to 5 with higher total score indicating higher level of consciousness

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Inpatients in one of the study sites
* Acquired brain injury resulting from either traumatic or non-traumatic events
* Diagnosis of MCS defined by CRS-R according to the Aspen criteria (Giacino, 2005)
* Informed consent as documented by signature by the patient's legal representative
* Physiologically stable
* Aged 18 or over

Exclusion Criteria:

* Phobia or allergies to any of the involved animals
* Medical contraindications: acute or chronic disease (e.g. chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes)
* Radical changes in medication (decision made with responsible physician)

+Locations (2)

FacilityCityCountryStatus
REHAB BaselBaselSwitzerlandRecruiting
Service de Neurorééducation, Hopitaux Universitaires GenevoisGenevaSwitzerlandRecruiting